塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/04 | 5,547 | 5,547 | 5,386 | 5,429 | -157 | -2.8% | 1,558,700 |
2021/03/03 | 5,576 | 5,600 | 5,540 | 5,586 | +72 | +1.3% | 928,100 |
2021/03/02 | 5,500 | 5,543 | 5,463 | 5,514 | +18 | +0.3% | 822,500 |
2021/03/01 | 5,522 | 5,553 | 5,465 | 5,496 | +83 | +1.5% | 819,000 |
2021/02/26 | 5,700 | 5,700 | 5,404 | 5,413 | -309 | -5.4% | 2,307,000 |
2021/02/25 | 5,895 | 5,897 | 5,722 | 5,722 | -99 | -1.7% | 1,323,700 |
2021/02/24 | 5,896 | 5,921 | 5,815 | 5,821 | +10 | +0.2% | 1,851,800 |
2021/02/22 | 5,866 | 5,924 | 5,811 | 5,811 | -93 | -1.6% | 867,900 |
2021/02/19 | 5,950 | 5,960 | 5,885 | 5,904 | -80 | -1.3% | 742,000 |
2021/02/18 | 6,066 | 6,085 | 5,959 | 5,984 | -63 | -1% | 1,059,600 |
2021/02/17 | 6,133 | 6,136 | 6,021 | 6,047 | -91 | -1.5% | 907,700 |
2021/02/16 | 6,075 | 6,170 | 6,058 | 6,138 | +68 | +1.1% | 1,011,500 |
2021/02/15 | 6,011 | 6,070 | 5,989 | 6,070 | +94 | +1.6% | 837,800 |
2021/02/12 | 6,072 | 6,080 | 5,963 | 5,976 | +4 | +0.1% | 1,519,100 |
2021/02/10 | 5,934 | 5,996 | 5,873 | 5,972 | +131 | +2.2% | 1,082,000 |
2021/02/09 | 5,906 | 5,922 | 5,811 | 5,841 | -100 | -1.7% | 865,900 |
2021/02/08 | 5,940 | 5,962 | 5,880 | 5,941 | +83 | +1.4% | 1,047,900 |
2021/02/05 | 5,776 | 5,863 | 5,761 | 5,858 | +129 | +2.3% | 1,114,000 |
2021/02/04 | 5,755 | 5,786 | 5,685 | 5,729 | -23 | -0.4% | 781,900 |
2021/02/03 | 5,650 | 5,752 | 5,611 | 5,752 | +146 | +2.6% | 1,034,500 |
2021/02/02 | 5,744 | 5,745 | 5,551 | 5,606 | -109 | -1.9% | 1,186,400 |
2021/02/01 | 5,697 | 5,766 | 5,602 | 5,715 | +35 | +0.6% | 1,032,800 |
2021/01/29 | 5,700 | 5,757 | 5,638 | 5,680 | -51 | -0.9% | 932,100 |
2021/01/28 | 5,670 | 5,733 | 5,623 | 5,731 | -30 | -0.5% | 1,096,700 |
2021/01/27 | 5,735 | 5,771 | 5,702 | 5,761 | +64 | +1.1% | 823,400 |
2021/01/26 | 5,768 | 5,778 | 5,691 | 5,697 | -54 | -0.9% | 698,500 |
2021/01/25 | 5,690 | 5,760 | 5,677 | 5,751 | +93 | +1.6% | 658,000 |
2021/01/22 | 5,654 | 5,696 | 5,601 | 5,658 | -25 | -0.4% | 901,700 |
2021/01/21 | 5,710 | 5,748 | 5,653 | 5,683 | -49 | -0.9% | 951,700 |
2021/01/20 | 5,711 | 5,745 | 5,666 | 5,732 | +44 | +0.8% | 1,010,800 |
2021/01/19 | 5,772 | 5,780 | 5,665 | 5,688 | -81 | -1.4% | 842,900 |
2021/01/18 | 5,818 | 5,823 | 5,742 | 5,769 | -21 | -0.4% | 607,900 |
2021/01/15 | 5,812 | 5,876 | 5,772 | 5,790 | -51 | -0.9% | 881,300 |
2021/01/14 | 5,843 | 5,888 | 5,786 | 5,841 | -44 | -0.7% | 960,000 |
2021/01/13 | 5,945 | 5,945 | 5,833 | 5,885 | -70 | -1.2% | 1,027,600 |
2021/01/12 | 5,940 | 5,999 | 5,860 | 5,955 | +114 | +2% | 1,276,600 |
2021/01/08 | 5,791 | 5,841 | 5,771 | 5,841 | +105 | +1.8% | 1,290,000 |
2021/01/07 | 5,680 | 5,788 | 5,680 | 5,736 | +142 | +2.5% | 1,624,000 |
2021/01/06 | 5,531 | 5,599 | 5,508 | 5,594 | +52 | +0.9% | 869,100 |
2021/01/05 | 5,634 | 5,634 | 5,526 | 5,542 | -85 | -1.5% | 838,800 |
2021/01/04 | 5,643 | 5,689 | 5,572 | 5,627 | -8 | -0.1% | 832,100 |
2020/12/30 | 5,712 | 5,712 | 5,630 | 5,635 | -44 | -0.8% | 804,100 |
2020/12/29 | 5,564 | 5,695 | 5,561 | 5,679 | +123 | +2.2% | 982,700 |
2020/12/28 | 5,542 | 5,602 | 5,514 | 5,556 | +39 | +0.7% | 689,500 |
2020/12/25 | 5,580 | 5,580 | 5,511 | 5,517 | -25 | -0.5% | 317,000 |
2020/12/24 | 5,545 | 5,568 | 5,527 | 5,542 | -31 | -0.6% | 480,000 |
2020/12/23 | 5,595 | 5,605 | 5,556 | 5,573 | -3 | -0.1% | 560,900 |
2020/12/22 | 5,570 | 5,606 | 5,545 | 5,576 | -64 | -1.1% | 718,100 |
2020/12/21 | 5,705 | 5,725 | 5,588 | 5,640 | -14 | -0.2% | 907,200 |
2020/12/18 | 5,562 | 5,674 | 5,541 | 5,654 | +75 | +1.3% | 1,464,400 |
1101~
1150
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム